CPT Code for COVID-19 Testing Now a CLIA-Waived Test
July 30, 2020
Effective for dates of service on or after June 25, 2020, CPT® code 87426 (Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) is now a Clinical Laboratory Improvement Amendments (CLIA)-waived test.
This code is intended for use as the industry standard for accurate reporting and tracking of antigen tests using immunofluorescent or immunochromatographic technique for the detection of biomolecules produced by coronavirus disease 2019 (COVID-19). It is a Medi-Cal benefit.
Updated manual pages will be released in a future Medi-Cal Update.